Has Babak Tousi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,578,651 in general payments to Babak Tousi, MD across 867 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Babak Tousi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Babak Tousi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Babak Tousi, MD

Geriatric Medicine · Cleveland, OHNPI 1720074495

Payments from drug & device makers

$8,578,651in general payments, 2019–2025

Across 867 payments — averaging $9894.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Eisai Inc.$3.4M
Biogen$3.2M
Janssen Research & Development, LLC$961K
Genentech, Inc.$577K
Novo Nordisk AS$213K
Avanir Pharmaceuticals, Inc.$116K
plus $166K from 10 others

$17,375in research payments, 2019–2025

Across 14 payments — averaging $1241.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novo Nordisk AS$13K
Novo Nordisk$2K
Acadia Pharmaceuticals Inc$2K

What the payments were for

Consulting fees$107,27350%
Speaking & faculty fees$54,77026%
Travel & lodging$46,00921%
Food & beverage$6,6213%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Eisai Inc.	552	$3,365,762
Biogen	43	$3,179,219
Janssen Research & Development, LLC	54	$960,618
Genentech, Inc.	32	$577,084
Novo Nordisk AS	76	$213,372
Avanir Pharmaceuticals, Inc.	9	$116,484
Grifols Biologicals LLC	3	$75,989
Lilly USA, LLC	69	$48,149
Novo Nordisk	6	$18,241
Eli Lilly	9	$11,096
Otsuka America Pharmaceutical, Inc.	2	$6,998
Corium, LLC	1	$3,220
Lundbeck LLC	2	$1,088
Otsuka Pharmaceutical Development & Commercialization, Inc.	6	$986
Genentech USA, Inc.	2	$242
Teva Pharmaceuticals USA, Inc.	1	$103

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,578,651 in reported general payments places this provider in the 95th percentile of 146 geriatric medicine providers in Ohio.

See all geriatric medicine providers in Ohio →

Medicare billing

Part B allowed, 2024

$53,748

Medicare patients

267

Services billed

510

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Rivastigmine	23	$5,528
Memantine Hcl	185	$4,418
Carbidopa	12	$3,662
Donepezil Hcl	493	$3,310
Droxidopa	12	$1,484
RivastigmineRivastigmine Tartrate	24	$1,385
Galantamine ErGalantamine Hbr	13	$1,210
Sertraline Hcl	167	$998
Quetiapine Fumarate	27	$520
Carbidopa-LevodopaCarbidopa/Levodopa	33	$417
Buspirone Hcl	30	$343
Mirtazapine	30	$333
Duloxetine Hcl	37	$300
Venlafaxine Hcl ErVenlafaxine Hcl	14	$202
Escitalopram Oxalate	26	$134

Paid to pharmacies, not to this prescriber.

Other geriatric medicine in Cleveland

Ronan FactoraCleveland$9K
Amanda LathiaCleveland$1K
Allan RosenfieldCleveland$1K
Rinku MukherjeeCleveland$437
Oliver AnchetaCleveland$341
Matthew WayneCleveland$303
Meenakshi PatelCenterville$3.9M
Robert KeyesCincinnati$624K
Daniel CannoneWadsworth$423K
James FidelholtzCincinnati$392K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →